Candidate Tumor-Suppressor Gene DLEC1 Is Frequently Downregulated by Promoter Hypermethylation and Histone Hypoacetylation in Human Epithelial Ovarian Cancer
Open Access
- 1 April 2006
- Vol. 8 (4), 268-278
- https://doi.org/10.1593/neo.05502
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Human ovarian carcinoma cells: Histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosisCancer, 2004
- Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer PatientsCancer Research, 2004
- Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomasOncogene, 2004
- Epigenetic Inactivation of TMS1/ASC in Ovarian CancerClinical Cancer Research, 2004
- Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomasOncogene, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Hypermethylation of the CpG island of theRASSF1A gene in ovarian and renal cell carcinomasInternational Journal of Cancer, 2001
- Mapping of chromosome 3p deletions in human epithelial ovarian tumorsOncogene, 1998
- Hereditary and sporadic ovarian cancer: genetic testing and clinical implications (review).International Journal of Oncology, 1998
- Genetic susceptibility to breast and ovarian cancer.1997